vs
Side-by-side financial comparison of COLONY BANKCORP INC (CBAN) and PROCEPT BioRobotics Corp (PRCT). Click either name above to swap in a different company.
PROCEPT BioRobotics Corp is the larger business by last-quarter revenue ($83.1M vs $39.9M, roughly 2.1× COLONY BANKCORP INC). COLONY BANKCORP INC runs the higher net margin — 20.6% vs -38.1%, a 58.6% gap on every dollar of revenue. Over the past eight quarters, PROCEPT BioRobotics Corp's revenue compounded faster (24.8% CAGR vs 19.6%).
Colony Bankcorp Inc is a US-based bank holding company that operates Colony Bank. It provides a full suite of personal and commercial banking services including deposit accounts, consumer and business loans, mortgage services, and wealth management solutions, primarily serving retail customers and small-to-medium enterprises across the state of Georgia.
PROCEPT BioRobotics Corp is a medical tech firm developing and commercializing robotic surgical solutions for urological care. Its flagship AquaBeam system provides image-guided minimally invasive therapy for benign prostatic hyperplasia, serving providers and patients across North America, Europe and global markets.
CBAN vs PRCT — Head-to-Head
Income Statement — Q1 FY2026 vs Q1 FY2026
| Metric | ||
|---|---|---|
| Revenue | $39.9M | $83.1M |
| Net Profit | $8.2M | $-31.6M |
| Gross Margin | — | 64.9% |
| Operating Margin | — | -4.1% |
| Net Margin | 20.6% | -38.1% |
| Revenue YoY | — | 20.2% |
| Net Profit YoY | 24.1% | -27.9% |
| EPS (diluted) | — | $-0.56 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | $39.9M | $83.1M | ||
| Q4 25 | $36.9M | $76.4M | ||
| Q3 25 | $32.8M | $83.3M | ||
| Q2 25 | $32.5M | $79.2M | ||
| Q1 25 | $30.0M | $69.2M | ||
| Q4 24 | $30.8M | $68.2M | ||
| Q3 24 | $28.6M | $58.4M | ||
| Q2 24 | $27.9M | $53.4M |
| Q1 26 | $8.2M | $-31.6M | ||
| Q4 25 | — | $-29.8M | ||
| Q3 25 | $5.8M | $-21.4M | ||
| Q2 25 | $8.0M | $-19.6M | ||
| Q1 25 | $6.6M | $-24.7M | ||
| Q4 24 | — | $-18.9M | ||
| Q3 24 | $5.6M | $-21.0M | ||
| Q2 24 | $5.5M | $-25.6M |
| Q1 26 | — | 64.9% | ||
| Q4 25 | — | 60.6% | ||
| Q3 25 | — | 64.8% | ||
| Q2 25 | — | 65.4% | ||
| Q1 25 | — | 63.9% | ||
| Q4 24 | — | 64.0% | ||
| Q3 24 | — | 63.2% | ||
| Q2 24 | — | 59.0% |
| Q1 26 | — | -4.1% | ||
| Q4 25 | 25.9% | -40.6% | ||
| Q3 25 | 22.2% | -27.8% | ||
| Q2 25 | 30.9% | -28.0% | ||
| Q1 25 | 27.6% | -39.7% | ||
| Q4 24 | 28.8% | -28.9% | ||
| Q3 24 | 24.6% | -38.4% | ||
| Q2 24 | 24.8% | -50.3% |
| Q1 26 | 20.6% | -38.1% | ||
| Q4 25 | — | -39.1% | ||
| Q3 25 | 17.7% | -25.7% | ||
| Q2 25 | 24.6% | -24.7% | ||
| Q1 25 | 22.0% | -35.8% | ||
| Q4 24 | — | -27.6% | ||
| Q3 24 | 19.7% | -35.9% | ||
| Q2 24 | 19.6% | -48.0% |
| Q1 26 | — | $-0.56 | ||
| Q4 25 | $0.42 | $-0.54 | ||
| Q3 25 | $0.33 | $-0.38 | ||
| Q2 25 | $0.46 | $-0.35 | ||
| Q1 25 | $0.38 | $-0.45 | ||
| Q4 24 | $0.43 | $-0.34 | ||
| Q3 24 | $0.32 | $-0.40 | ||
| Q2 24 | $0.31 | $-0.50 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | ||
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $295.8M | $245.6M |
| Total DebtLower is stronger | — | $51.7M |
| Stockholders' EquityBook value | $380.4M | $347.7M |
| Total Assets | $3.7B | $487.1M |
| Debt / EquityLower = less leverage | — | 0.15× |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | $295.8M | $245.6M | ||
| Q4 25 | — | $286.5M | ||
| Q3 25 | — | $294.3M | ||
| Q2 25 | — | $302.7M | ||
| Q1 25 | — | $316.2M | ||
| Q4 24 | — | $333.7M | ||
| Q3 24 | — | $196.8M | ||
| Q2 24 | — | $214.1M |
| Q1 26 | — | $51.7M | ||
| Q4 25 | $258.1M | $51.6M | ||
| Q3 25 | — | $51.6M | ||
| Q2 25 | — | $51.5M | ||
| Q1 25 | — | $51.5M | ||
| Q4 24 | $248.0M | $51.5M | ||
| Q3 24 | — | $51.4M | ||
| Q2 24 | — | $51.4M |
| Q1 26 | $380.4M | $347.7M | ||
| Q4 25 | $375.9M | $365.9M | ||
| Q3 25 | $302.3M | $380.3M | ||
| Q2 25 | $293.9M | $385.8M | ||
| Q1 25 | $286.9M | $389.2M | ||
| Q4 24 | $278.7M | $402.2M | ||
| Q3 24 | $276.1M | $241.2M | ||
| Q2 24 | $264.7M | $251.8M |
| Q1 26 | $3.7B | $487.1M | ||
| Q4 25 | $3.7B | $508.1M | ||
| Q3 25 | $3.2B | $511.5M | ||
| Q2 25 | $3.1B | $513.1M | ||
| Q1 25 | $3.2B | $519.4M | ||
| Q4 24 | $3.1B | $534.0M | ||
| Q3 24 | $3.1B | $374.1M | ||
| Q2 24 | $3.0B | $374.4M |
| Q1 26 | — | 0.15× | ||
| Q4 25 | 0.69× | 0.14× | ||
| Q3 25 | — | 0.14× | ||
| Q2 25 | — | 0.13× | ||
| Q1 25 | — | 0.13× | ||
| Q4 24 | 0.89× | 0.13× | ||
| Q3 24 | — | 0.21× | ||
| Q2 24 | — | 0.20× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
CBAN
| Net Interest Income | $29.2M | 73% |
| Noninterest Income | $10.7M | 27% |
PRCT
| Handpieces and other consumables | $43.0M | 52% |
| System sales and rentals | $23.4M | 28% |
| Other | $11.1M | 13% |
| Service | $5.6M | 7% |